Search Articles
PHILADELPHIA – GlaxoSmithKline can tack another $46 million to its settlement of Flonase antitrust claims, covering the claims from indirect purchasers of the nasal spray, a federal judge ruled.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.